You are viewing: South Korea Spatial Genomics & Transcriptomics Market analysis

The South Korea Spatial Genomics & Transcriptomics Market was valued at $5.94 Million in 2024 and projected to reach to $10.99 Million by 2029, representing a compound annual growth rate of 13.1%. South Korea's spatial genomics and transcriptomics market is positioned for accelerated growth through 2029, supported by the nation's commitment to precision medicine and genomic research excellence.

South Korea Spatial Genomics & Transcriptomics Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Spatial Genomics & Transcriptomics Market Trends and Insights

  • This 13.1% compound annual growth rate reflects South Korea's strong investment in precision medicine infrastructure and advanced genomic research capabilities.
  • South Korea's leadership in biotechnology innovation, coupled with government support for life sciences R&D, positions the country as a key regional hub for spatial genomics adoption. The market expansion in South Korea is driven by increasing demand for high-resolution spatial analysis tools in cancer research, neurobiology, and developmental biology applications.
  • South Korea's robust healthcare system and well-established pharmaceutical sector create favorable conditions for commercialization of spatial transcriptomics platforms.
  • Between 2024 and 2029, South Korea is expected to see accelerated adoption across academic research institutions, clinical diagnostics centers, and biopharmaceutical companies seeking to integrate spatial genomics into their discovery pipelines..

Key Market Statistics

  • CAGR (2024-2029) 13.1% CAGR
  • Market Size, 2024 ~USD 5.94 Million
  • Forecast, 2029 ~USD 10.99 Million
  • Country South Korea

South Korea Spatial Genomics & Transcriptomics Market Overview

Market Valuation & Growth :

South Korea's spatial genomics and transcriptomics market reached $5.94 million in 2024, with a robust 13.1% CAGR projected through 2029, outpacing the global average of 12.4%.

Precision Medicine Leadership :

South Korea's advanced healthcare infrastructure and government support for precision medicine initiatives are driving adoption of spatial genomics technologies across research institutions and clinical laboratories.

Biotechnology Innovation Hub :

The country's strong biotechnology sector, supported by major research centers and pharmaceutical companies, is accelerating development and commercialization of spatial transcriptomics platforms and applications.

Forecast Expansion :

The market is anticipated to reach $10.99 million by 2029, representing an 85% increase from 2024, driven by increased R&D investments and clinical adoption in oncology and neuroscience research.

South Korea Spatial Genomics & Transcriptomics Market Dynamics

  • Government funding initiatives, coupled with collaborations between academic institutions and biotech companies, are expanding the adoption of spatial analysis technologies across cancer research, neurodegenerative disease studies, and drug development pipelines. The competitive landscape is strengthening as South Korean biotech firms develop indigenous spatial genomics solutions and establish partnerships with global technology providers.
  • Increasing clinical applications, rising healthcare expenditure, and the country's aging population driving demand for advanced diagnostic tools will sustain market momentum.
  • By 2029, South Korea is expected to emerge as a significant regional hub for spatial genomics innovation and commercialization in Asia-Pacific..

Market Ecosystem

logo-mobile

SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Visium and Xenium platforms enable spatial gene expression analysis in intact tissues for oncology research, cellular mapping, biomarker discovery, and tissue heterogeneity studies. Enables high-resolution spatial profiling | Supports cellular and tissue-level analysis | Facilitates biomarker discovery and translational research
company logo
The CosMx Spatial Molecular Imager enables high-plex spatial RNA analysis to investigate cellular interactions, tumor microenvironments, and gene expression in oncology, neuroscience, and immunology. Enables detailed spatial gene expression analysis | Preserves tissue architecture | Supports investigation of cellular interactions and disease mechanisms
company logo
Sequencing platforms and reagents support sequencing-based spatial transcriptomics workflows for tissue profiling, disease research, biomarker discovery, and translational studies. Supports high-throughput sequencing and downstream spatial data analysis | Enables gene expression profiling | Facilitates integration of spatial transcriptomics with broader genomic research

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Key Takeaways

  • South Korea's spatial genomics market is valued at $5.94 million in 2024 and will reach $10.99 million by 2029, representing a 13.1% CAGR.
  • South Korea's advanced biotechnology infrastructure and government R&D funding are primary catalysts for market expansion through 2029.
  • South Korea's pharmaceutical and diagnostic sectors are increasingly adopting spatial transcriptomics for precision medicine applications.
  • South Korea's academic and research institutions are driving innovation and commercialization of spatial genomics technologies in the Asia-Pacific region.

Spatial Genomics & Transcriptomics Market Report Scope

Report Metric Details
Base Year 2024
Fastest Growing Segment SERVICES (Offering)
Forecast Period 2024-2029
Growth Rate CAGR of 12.4% from 2024 to 2029
Largest Segment PRODUCTS (Offering)
Market Size Base Year (Billions) ~USD 0.56 (2024)
Revenue Forecast (Billions) ~USD 0.9957 (2029)
Segments Covered Offering, Type, Technique, Application, End User

South Korea Spatial Genomics & Transcriptomics Market Report Segmentation

5 segment dimensions are covered across the global market.

By Offering

  • Products
  • Services

By Type

  • Cancer
  • Chromatin Accessibility Sequencing
  • Consumables
  • Data Visualization & Analysis Services
  • Genomic Sequencing
  • Immunofluorescence
  • Immunohistochemistry
  • Immunology
  • In-Situ Hybridization
  • In-Situ Rna Sequencing
  • Infectious Diseases
  • Instruments & Software
  • Laser Capture Microdissection
  • Microdissection-Based Sequencing
  • Microscopy-Based Rna Imaging
  • Microscopy-Based Rna Imaging Techniques
  • Neuroscience
  • Other Diseases
  • Other Genomic Sequencing
  • Other Genomic Sequencing \
  • Other Rna Sequencing
  • Other Spatial Genomics Techniques
  • Other Spatial Transcriptomic Techniques
  • Other Spatial Transcriptomics Techniques
  • Rna Sequencing
  • Rna Sequencing Techniques
  • Sample Preparation Services
  • Sequencing & Analytical Services
  • Single-Cell Rna Sequencing

By Technique

  • Spatial Genomics
  • Spatial Transcriptomics

By Application

  • Drug Discovery & Development
  • Translational Research

By End User

  • Academic & Research Institutes
  • Clinical Diagnostic Laboratories
  • Cros & Cdmos
  • Other End Users
  • Pharmaceutical & Biotechnology Companies

Target Audience

  • Biotech & Genomics Companies : South Korean and international biotech firms need market-specific data to assess expansion opportunities, competitive positioning, and clinical adoption rates in the spatial genomics sector.
  • Healthcare & Diagnostic Providers : Hospital networks, diagnostic laboratories, and clinical research organizations require insights into spatial transcriptomics adoption, technology ROI, and integration strategies for precision medicine programs.
  • Investment & Venture Capital Firms : Investors targeting South Korea's biotech sector need detailed market forecasts, growth drivers, and emerging opportunities to identify high-potential spatial genomics startups and technologies.
  • Pharmaceutical & Research Institutions : Pharma R&D teams and academic research centers need South Korea-specific market intelligence to guide drug development strategies, research collaborations, and technology adoption decisions.
  • Government & Policy Makers : Healthcare policymakers and government agencies require market data to inform precision medicine initiatives, research funding allocations, and regulatory frameworks for spatial genomics technologies.

Reasons to Buy this Report

  • Market-Specific Growth Intelligence : Gain detailed insights into South Korea's 13.1% CAGR trajectory, understanding local market drivers, regulatory environment, and investment patterns distinct from global trends.
  • Competitive Landscape Analysis : Identify key South Korean biotech players, research institutions, and technology providers shaping the spatial genomics ecosystem and their strategic positioning through 2029.
  • Clinical Application Opportunities : Understand adoption patterns across South Korean hospitals, research centers, and pharmaceutical companies in oncology, neuroscience, and personalized medicine applications.
  • Investment & Partnership Strategy : Access actionable intelligence on funding trends, government initiatives, and collaboration opportunities within South Korea's precision medicine and genomics research sectors.
  • Regional Market Expansion Planning : Leverage South Korea-specific data to develop market entry strategies, localization approaches, and growth tactics for Asia-Pacific expansion in spatial genomics technologies.

Frequently asked questions

What is the current market size of spatial genomics in South Korea?

South Korea's spatial genomics and transcriptomics market was valued at $5.94 million in 2024 and is expected to grow to $10.99 million by 2029.

What is the projected growth rate for South Korea's spatial genomics market?

South Korea's spatial genomics market is projected to grow at a compound annual growth rate (CAGR) of 13.1% from 2024 to 2029.

Which sectors in South Korea are driving spatial genomics adoption?

South Korea's pharmaceutical companies, clinical diagnostics centers, and academic research institutions are the primary drivers of spatial genomics adoption.

Why is South Korea a key market for spatial transcriptomics?

South Korea's advanced biotechnology infrastructure, government support for life sciences R&D, and strong healthcare system make it a strategic hub for spatial genomics innovation and commercialization.

What applications are most prevalent in South Korea's spatial genomics market?

South Korea's spatial genomics market is primarily focused on cancer research, neurobiology, and developmental biology applications within precision medicine.

RESEARCH METHODOLOGY

This research study extensively utilized secondary sources, directories, and databases to identify and collect valuable information for analyzing the global spatial genomics & transcriptomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size.

Secondary Research

Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the spatial genomics & transcriptomics market. The secondary sources referred to for this research study include publications from government sources, such as the World Health Organization (WHO), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), International Agency for Research on Cancer (IARC), Research!America, Genome Canada, GenomeWeb, South African Medical Research Council (SAMRC), Wellcome Sanger Institute, Genome Research Limited, Labiotech.eu, R&D World Magazine, India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, and Eurostat, among others.

Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements), business magazines and research journals, press releases, and trade, business, and professional associations. Secondary data was collected and analyzed to determine the overall size of the global market, which was validated through primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

Spatial Genomics and Transcriptomics Market
 Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate & validate the total size of the spatial genomics & transcriptomics market. These methods were also used extensively to estimate the size of various market segments.

Spatial Genomics and Transcriptomics Market Top Down and Bottom Up Approach

Data Triangulation

After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data were triangulated by analyzing various factors and trends from the demand and supply sides.

Market Definition

Spatial genomics and transcriptomics are pioneering technologies that allow scientists to measure gene activity in a tissue sample and map the site of the activity. Spatial transcriptomics helps spatially resolve RNA-seq data and all mRNAs in individual tissue sections. The technology is presently used in translational research and can be used in clinical diagnosis in the future. Spatial genomics also helps map gene expression across human tissues.

The scope of the market encompasses the tools, technologies, and services used to explore the spatial distribution and organization of genetic material and gene expression within cells and tissues.

Key Stakeholders

  • Manufacturers and distributors
  • Service providers
  • Pharmaceutical and biotechnology companies
  • Contract research organizations (CROs)
  • Contract development & manufacturing organizations (CDMOs)
  • Market research and consulting firms
  • R&D centers
  • Researchers and scientists
  • Academic & research institutes
  • Market research and consulting firms
  • Regulatory agencies
  • Venture capitalists
  • Government organizations
  • Industry associations and professional societies

Report Objectives

  • To define, describe, and forecast the spatial genomics & transcriptomics market based on offering, technique (products), type (services), application, end user (products), end user (services), and region, in terms of value
  • To forecast the size of the market segments concerning six main regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
  • To provide detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the market growth
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically profile the key players in the market and comprehensively analyze their core competencies and market rankings
  • To track and analyze competitive developments, such as product & service launches, acquisitions, expansions, agreements, partnerships, and collaborations, in the market
  • To benchmark players within the market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

Available customizations:

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

  • Further breakdown of the Rest of Europe spatial genomics & transcriptomics market, by country
  • Further breakdown of the Rest of Asia Pacific spatial genomics & transcriptomics market, by country
  • Further breakdown of the Rest of Latin America spatial genomics & transcriptomics market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

 

Get the Full Spatial Genomics & Transcriptomics Market Report

Full forecast, segment splits, and company analysis for all Spatial Genomics & Transcriptomics Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status